Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Immunic Inc (NASDAQ: IMUX) closed at $1.16 in the last session, down -2.52% from day before closing price of $1.19. In other words, the price has decreased by -$2.52 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
We take a closer look at IMUX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 2.71. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 25, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
On August 27, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $6.B. Riley Securities initiated its Buy rating on August 27, 2024, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Rudick Richard Alan bought 87,300 shares for $1.15 per share. The transaction valued at 100,369 led to the insider holds 87,300 shares of the business.
Stock Price History:
Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 11.48%, while the 200-Day Moving Average is calculated to be -7.87%.
Shares Statistics:
A total of 90.08M shares are outstanding, with a floating share count of 87.36M. Insiders hold about 3.02% of the company’s shares, while institutions hold 57.11% stake in the company.
